Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A., Barba, P. ... Yakoub Agha, I. (2023). Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations. Blood, 142. (10), 865-877. doi: 10.1182/blood.2023020578
Rejeski, Kai, et al. "Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations." Blood, vol. 142, no. 10, 2023, pp. 865-877. https://doi.org/10.1182/blood.2023020578
Rejeski, Kai, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Pere Barba, Benedetto Bruno, et al. "Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations." Blood 142, no. 10 (2023): 865-877. https://doi.org/10.1182/blood.2023020578
Rejeski, K., et al. (2023) 'Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations', Blood, 142(10), pp. 865-877. doi: 10.1182/blood.2023020578
Rejeski K, Subklewe M, Aljurf M, Bachy E, Balduzzi A, Barba P, and sur.. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations. Blood [Internet]. 2023 September 07 [cited 2024 August 20];142(10):865-877. doi: 10.1182/blood.2023020578
K. Rejeski, et al., "Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations", Blood, vol. 142, no. 10, pp. 865-877, September 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:656065. [Accessed: 20 August 2024]